CONMED Corp
For the period ended May 20, 2025. Filed Apr 8, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 20, 2025 · Filed Apr 8, 2025
Contents
PROXY STATEMENT SUMMARY
This summary highlights information contained elsewhere in this Proxy Statement. This summary does not contain all the information that you should consider, and as a result, we encourage you to read the entire Proxy Statement and the Company’s most recent Annual Report on Form 10-K before casting your vote. References to ‘‘CONMED,’’ the ‘‘Company,’’ ‘‘we,’’ ‘‘us’’ or ‘‘our’’ refer to CONMED Corporation and its subsidiaries.
Summary of Proposals to be Voted on at the Annual Meeting
| For MoreInformation | Board Recommendation | ||
| PROPOSAL 1 – Election of Directors | Pages 8-28 | FOR each Nominee | |
|---|---|---|---|
| Patrick J. Beyer | Charles M. Farkas | ||
| David Bronson | Martha Goldberg Aronson | ||
| Brian P. Concannon | Mark Kaye | ||
| LaVerne Council | Barbara J. Schwarzentraub | ||
| PROPOSAL 2 – Say on Pay | Pages 29-69 | FOR | |
| Advisory Vote on Named Executive Officer Compensation | |||
| PROPOSAL 3 – Approval of the 2025 Long-Term Incentive Plan | Pages 70-83 | FOR | |
| PROPOSAL 4 – Ratification of the Appointment of PricewaterhouseCoopers LLP for fiscal 2025 | Pages 84-87 | FOR | |
| 2025 Proxy Statement | 1 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.